These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29439639)

  • 21. Ex vivo thrombin generation in patients with venous thromboembolic disease or atrial fibrillation on long-term oral anticoagulation.
    Musial J; Brzezinska-Kolarz B; Zólcinski M; Lelakowski J; Szczeklik A
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):614-21. PubMed ID: 20460350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulation for cardiac surgery in patients receiving preoperative heparin: use of the high-dose thrombin time.
    Shore-Lesserson L; Manspeizer HE; Bolastig M; Harrington D; Vela-Cantos F; DePerio M
    Anesth Analg; 2000 Apr; 90(4):813-8. PubMed ID: 10735781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel oral anticoagulants in the management of coronary artery disease.
    McMahon SR; Brummel-Ziedins K; Schneider DJ
    Coron Artery Dis; 2016 Aug; 27(5):412-9. PubMed ID: 27228186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study.
    Dietrich W; Dilthey G; Spannagl M; Jochum M; Braun SL; Richter JA
    Anesthesiology; 1995 Oct; 83(4):679-89; discussion 29A-30A. PubMed ID: 7574046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance.
    Donovan JL; Drake JA; Whittaker P; Tran MT
    J Thromb Thrombolysis; 2006 Aug; 22(1):23-30. PubMed ID: 16786229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
    Gatt A; van Veen JJ; Woolley AM; Kitchen S; Cooper P; Makris M
    Thromb Haemost; 2008 Aug; 100(2):350-5. PubMed ID: 18690358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced anticoagulant activity of enoxaparin in patients with ESRD as measured by thrombin generation time.
    Brophy DF; Martin EJ; Gehr TW; Carr ME
    Am J Kidney Dis; 2004 Aug; 44(2):270-7. PubMed ID: 15264185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between changes in F1+2 and TAT levels and blood coagulation early after prosthetic valve replacement.
    Nakamura K; Toyohira H; Kariyazono H; Yamada K; Moriyama Y; Taira A
    Thromb Res; 1997 Apr; 86(2):161-71. PubMed ID: 9175237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signs of thrombin generation in pediatric cardiac catheterization with unfractionated heparin bolus or subcutaneous low molecular weight heparin for antithrombotic cover.
    Roschitz B; Beitzke A; Gamillscheg A; Sudi K; Koestenberger M; Leschnik B; Muntean W
    Thromb Res; 2003; 111(6):335-41. PubMed ID: 14698650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-effect relationship for several coagulation markers during administration of the direct thrombin inhibitor S 18326 in healthy subjects.
    Gaussem P; Dubar M; le Bonniec B; Richard-Lordereau I; Jochemsen R; Aiach M
    Br J Clin Pharmacol; 2002 Feb; 53(2):147-54. PubMed ID: 11851638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
    Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
    Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease.
    Linder R; Oldgren J; Egberg N; Grip L; Larson G; Siegbahn A; Wallentin L
    Eur Heart J; 1999 Apr; 20(7):506-18. PubMed ID: 10365287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathology consultation on anticoagulation monitoring: factor X-related assays.
    Wool GD; Lu CM;
    Am J Clin Pathol; 2013 Nov; 140(5):623-34. PubMed ID: 24124140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
    Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ; Ofosu FA; Buchanan MR
    Thromb Haemost; 1993 Aug; 70(2):259-62. PubMed ID: 8236131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
    Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
    Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know.
    Conway SE; Hwang AY; Ponte CD; Gums JG
    Pharmacotherapy; 2017 Feb; 37(2):236-248. PubMed ID: 27983747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan.
    Tanaka KA; Szlam F; Vinten-Johansen J; Cardin AD; Levy JH
    Thromb Haemost; 2005 Oct; 94(4):808-13. PubMed ID: 16270635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent thrombin generation in humans during specific thrombin inhibition with hirudin.
    Zoldhelyi P; Bichler J; Owen WG; Grill DE; Fuster V; Mruk JS; Chesebro JH
    Circulation; 1994 Dec; 90(6):2671-8. PubMed ID: 7994807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.